Shows
TGen TalksEpisode 85: Runway for ResearchWhat connects a fashion show to biomedical research? More than you'd expect—especially in the fight against women’s cancers and the local support for TGen and City of Hope.
TGen’s 5th annual Runway for Research takes place on Friday, October 17, in partnership with Neiman Marcus, Scottsdale Fashion Square, and City of Hope Phoenix.
Runway for Research blends fashion and purpose, supporting advancements in women’s cancer research and treatment. Attendees will experience the season’s latest runway trends, connect with community leaders, and support groundbreaking local research.
In this episode of TGen Talks, Runway co-chairs Lee Courtney and Amy Hair spotlight R...
2025-08-2712 min
TGen TalksEpisode 84 Precision MedicineWhat if medicine worked to get you healthier overall—not just people like you or for one or another symptom? In the latest episode of TGen Talks, host Karie Dozer sits down with Nicholas Schork, Ph.D., and Laura Goetz, M.D., co-authors of a recent commentary published in Nature Communications, From Precision Interventions to Precision Health, to explore the promise—and complexity—of truly personalized healthcare.
Traditional medicine treats symptoms. Precision healthcare, however, rethinks that model entirely. By tapping into genomics, environment, lifestyle, and even real-time data from wearable devices, Drs. Schork and Goetz discuss developing highly individualized approaches that d...
2025-07-2926 min
TGen TalksEpisode 83: Discovering a Future in Science — The Helios Scholars at TGen ProgramSummers at TGen offer a unique opportunity for students to dive into the world of biomedical research. The Helios Scholars Program at TGen actively engages student interns in real-world science and administrative functions, as they gain practical experience and contribute to ongoing projects.
Join host Karie Dozer as Helios Scholar Audra Welch shares her unfiltered experience in the intensive eight-week program. Discover how this Northern Arizona University biology and Spanish major is diving headfirst into biomedical research, specifically exploring how age influences the brain's response to sepsis.
Audra candidly discusses the thrill and challenge of wet lab work, building on the...
2025-06-2417 min
TGen TalksEpisode 82: The Ivy Neurological Sciences Internship Program at TGenIn this episode of TGen Talks, we spotlight the Ivy Neurological Sciences Internship Program at TGen. This year-long program bridges the gap between undergraduate studies and medical school, providing aspiring physicians with direct laboratory experience. Interns actively participate in ongoing research, often leading independent projects.
Joining our podcast is Ivy Intern, Megan Locklear, who’s completing a year-long internship working in the glioblastoma lab before entering medical school. Her work exemplifies how TGen empowers the next generation of medical researchers. Join us as we discuss her experiences and the impact of this unique internship.
The year of lab work has ta...
2025-05-2818 min
TGen TalksEpisode 81: Accelerating Discovery to MarketThis month on TGen Talks, we get an insider’s perspective on how today’s biomedical research translates into tomorrow's treatments. We sit down with Stephanie Pond, Ph.D., Vice President of Emerging Opportunities at TGen.
We’ll Learn about the crucial role of TGen’s START and EDP programs – the Scientific Technology Assessment Research Team and Enterprise Directed Programs – in accelerating this process.
Dr. Pond explains how her team works to identify gaps in current research tools, partner with biotechnology companies to develop new technologies, and help commercialize TGen’s research discoveries. She highlights how advances in multiomics, single-cell sequencing, an...
2025-04-3019 min
TGen TalksEpisode 39: A TGen OverviewScience has come a remarkably long way, especially since sequencing the human genome, but has it come far enough for everyone?
A focus of TGen research has always been finding a path to the clinic and ensuring the work is relevant to patients in need. But that’s not always easy.
Jeffrey Trent Ph.D., F.A.C.M.G., TGen's Founding President and Research Director, on episode 39 of TGen Talks, discusses how investigators at TGen headquarters continued their research into various cancers and other diseases without missing a beat while most of the world was on COVID lockdown, and sh...
2025-03-2810 min
TGen TalksEpisode 58: Tracing Ancient History with Modern ScienceUnderstanding how infectious diseases spread in the past is important to understanding how they affect populations today. The difficulty lie in piecing together information given that so little is known about how microbes spread historically.
Applying academic rigor with scientific assessment, two microbiologists teamed with an archaeologist to look at different types of evidence — genetics, anthropology, paleontology and climate — in an attempt to explain how the fungus that causes Valley fever, Coccidioides immitis, ended up in a specific area of Washington state. The review article in mBio by Drs. David Engelthaler, James C. Chatters and Arturo Casadevall details their approach from...
2025-03-2817 min
TGen TalksEpisode 80: A Spatial Map of Pulmonary FibrosisPulmonary Fibrosis. A debilitating disease that restricts a person’s lung capacity, controllable with drug therapies, but it’s only “cure” is a double lung transplant. Researchers at TGen have released the results of a study that investigated the disease on a cellular level. Using advanced spatial transcriptomics, they identified hidden disease markers in seemingly healthy lung tissue—offering hope for earlier, more personalized treatments. Targeting these early disruptions could improve lung function and outcomes. With current PF treatments only slowing decline, this discovery, published in Nature Genetics, marks a step toward preventing irreversible damage. In this episode of TGen Talks, Nic...
2025-03-2624 min
TGen TalksEpisode 79, Breaking Barriers: How Women in Science Help Shape the FutureIn this episode of TGen Talks, which celebrates Women’s History Month (March), we’ll explore how women in science have shaped the world around us, and how their stories continue to inspire future generations of young women to become researchers, leaders, and trailblazers who continue to break barriers.
Joining the podcast this month is Bethany Davis, Ph.D., an enrolled member of the Turtle Mountain Band of Chippewa Indians and a Research Assistant Professor in TGen’s Clinical Genomics and Therapeutics Division. Davis specializes in studying the effects of environmental toxins, like heavy metals, and other conditions that affect the kidn...
2025-02-2516 minTGen TalksEpisode 79: Breaking Barriers — How Women in Science Help Shape the FutureIn this episode of TGen Talks, which celebrates Women’s History Month (March), we’ll explore how women in science have shaped the world around us, and how their stories continue to inspire future generations of young women to become researchers, leaders, and trailblazers who continue to break barriers.
Joining the podcast this month is Bethany Davis, Ph.D., an enrolled member of the Turtle Mountain Band of Chippewa Indians and a Research Assistant Professor in TGen’s Clinical Genomics and Therapeutics Division.
Davis specializes in studying the effects of environmental toxins, like heavy metals, and other conditions that affect the ki...
2025-02-2516 min
TGen TalksThe Power of NanotherapeuticsWhat if the cure for diseases like Alzheimer’s or cancer lay hidden inside the immune systems of llamas, cows, or even sharks?
On this episode of TGen Talks, TGen’s newest faculty member, Dr. John Fryer, introduces us to the world of nanotherapeutics—a new class of biologics derived from the unique immune systems of animals like camels and sharks. These ultra-small molecules, known as “nanobodies,” are revolutionizing the way we think about treating diseases like Alzheimer’s, cancer, and even sepsis.
Dr. Fryer explains how these tiny molecules—about 10 times smaller than traditional monoclonal antibodies—can target tough-to-reach areas like the brain, offe...
2025-01-2820 min
TGen TalksGlyphosate’s Long-Lasting Effects on Brain HealthScientists have long known that farm chemicals can be harmful to human health. Many lawn and garden products used by consumers carry warnings, so that users can protect themselves when applying herbicides in their own yards.
But which chemicals are the most dangerous? And how much exposure is too much to be considered safe?
A new study from TGEN and Arizona State University is shedding light on glyphosate, a common chemical in many herbicides, and its findings indicate that not only does glyphosate cross the blood brain barrier, but its damaging effects on the brain can remain long after the exposur...
2024-12-0419 min
TGen TalksEpisode 76: Leigh Nicholson, Ph.D., Researcher and AmbassadorOn this month’s TGen Talks, our host sits down with Leigh Nicholson, Ph.D., who was recently named a research assistant professor in TGen’s Early Detection and Prevention Division. Nicholson studies neurological diseases of all kinds — from the rarest to the very common — including a childhood disorder called Okur-Chung neurodevelopmental syndrome, or OCNDS for short, and Alzheimer’s disease, which affects nearly 7 million Americans. The podcast covers her path to a career in science, her day-to-day research, and why she thinks mentoring young scientists and improving scientific literacy is so important. All this and more, in just under 15 minutes.
2024-10-3014 min
Scottsdale VibesTGen Runway for Research KickoffWhen we think of October many of us think fall, Halloween, maybe sweater weather if it ever decides to cool down! But to thousands of women, and men, out there, October is Breast Cancer Awareness Month. According to the National Breast Cancer Foundation 1 in 8 women in the United States will be diagnosed with breast cancer in her lifetime. In 2024, over 300,000 women & men will be diagnosed with invasive breast cancer. Chances are, you know at least one person who has been personally affected by breast cancer. But there is hope. When caught in its earliest, localized stages, the 5-year relative...
2024-10-0714 min
TGen TalksA Postdoc’s Perspective: Dr. Aya Kamzina’s Path to ResearchEvery September, the scientific community recognizes postdoctoral researchers during Postdoc Appreciation Week. Postdocs bring new ideas and deep expertise as they tackle complex questions and expand knowledge through experiments.
In this month’s episode of TGen Talks, Aya Kamzina, Ph.D., one of TGen’s 11 postdoctoral researchers, shares her journey to becoming a postdoc and her experiences at TGen.
Dr. Kamzina’s educational path began in Kazakhstan and differs from many of her peers. She discusses her work with organoids and microglia in Dr. Huentelman’s neurogenomics lab, as well as her diverse background in biochemical engineering and molecular biology.
Dr. Kamzina also...
2024-09-2615 min
TGen TalksEpisode 74: Breaking Down Multiple Myeloma’s New Subtypes and Their ImpactScientists at TGen have released the results of a more than decade-long study into multiple myeloma. Looking at more than 1100 patients from four different countries, scientists identified new genetic subtypes of the disease, providing insights that could transform how we approach treatment (see related story above).
Listen as Jonathan Keats, Ph.D., the study's senior author discusses the findings, their impact on personalized medicine, and how TGen's advanced genomic sequencing is paving the way for more effective and individualized care. In particular, the study has identified a high-risk subgroup of patients with a distressingly short median survival, highlighting the urgent...
2024-08-2816 min
TGen TalksEpisode 73: The Science of LongevityAging. It’s something we’d all like to do better.
Americans spend an estimated $5 Billion on anti-aging products every year. But at TGen and City of Hope, scientists like TGen distinguished professor Nicholas Schork, Ph.D., are working to unlock the secrets to not just better ‘aging,’ but disease prevention alongside longevity, and are making promising progress toward medications and methods that will be tailored to each specific person, rather than those that promise longer healthier lives for all.
In this episode of TGen Talks, our host Karie Dozer sits down with Schork to discuss the groundbreaking search for substanc...
2024-07-3024 min
TGen TalksEpisode 72: Fowl Play: Viewing the New Strain of Bird Flu Through a Genomic LensOn this month’s TGen Talks, David Engelthaler, Ph.D., professor and director of TGen’s Pathogen and Microbiome Division, discusses the recent surge of bird flu, also known as H5N1.
H5N1 has been in the news a lot lately, but what does it all mean? Engelthaler breaks down the science and talks about the effects this particular strain might have on humans. He also explains what constitutes an outbreak, how they fade over time, and why they start anew.
Bird flu, like other influenza viruses, changes and mutates over time, and the H5N1 strain is particularly concerni...
2024-06-2719 min
TGen TalksEpisode 71: Understanding Your Risk with a PRSThis month, TGen Talks explores polygenic risk scores with Dr. David Duggan, an associate professor in the Quantitative Medicine and Systems Biology Division at TGen. A polygenic risk score is a number that indicates the combined effect of many genetic variants on a person's risk of developing a certain trait or disease. Each genetic variant adds a small amount to the overall risk. When these small effects are added together, they help predict the likelihood of developing the trait or disease.
Think of the human genome as a deck of cards, where each card represents a different genetic variant. The value o...
2024-05-2820 min
TGen TalksEpisode 70: United Against Brain CancerGlioblastoma. It’s the most aggressive and least treatable type of brain cancer. Research into treatment has been slow, mostly because of the difficulty in accessing and treating a tumor that exists behind the blood-brain barrier.
A new two year fellowship into Glioblastoma Multiforme, or GBM, aims to better drug therapies to fight the cancer while developing better tests to determine which drugs are working on an individual patient's tumor and which are not.
The fellowship, established by Shawn Lane and the Lori Lane Foundation together with Chris and Florence Spyrow, honors Lori Lane and Andrew Spyrow, whose lives were cut shor...
2024-04-2915 min
TGen TalksEpisode 69 – Beyond the Surface: Inside the Science of Skin CancerIn this episode of TGen Talks, we explore the overlooked yet vital world of skin cancer prevention and treatment. Our skin, the body's largest organ, often takes a back seat in discussions about cancer. Join us as we delve into this crucial topic with our guest, Dr. Aleksandar Sekulic.
Dr. Sekulic wears two hats: that of a clinician and a researcher. He shares how his interactions with patients inform his research, leading to groundbreaking advancements in skin cancer treatment. From pioneering clinical trials to developing targeted therapies and immunotherapies, Dr. Sekulic sheds light on the complexities of skin cancer and the i...
2024-03-2924 min
TGen TalksTGen Talks LiveCancer continues to be the second most common cause of death in the United States, with a total of nearly 2 million diagnoses every year.
In this episode of TGen Talks, recorded in front of a live studio audience, we take a look at how genomic information is leading to better and earlier diagnoses and treatments for all kinds of cancer and how the collaboration between City of Hope Cancer Center Phoenix and TGen is proving to be a mighty weapon in the fight against cancer right here in Arizona.
Joining the podcast this month are TGen President and Research Director, Dr...
2024-02-2821 min
TGen TalksEpisode 67: Tiny particles offer big clues toward predicting Alzheimer’s decades in advanceAlzheimer’s disease affects an estimated six million Americans. Diagnosing and treating the disease is challenging, and for families taking care of a loved one with Alzheimer’s, it’s even more difficult. Detecting and addressing the disease early on is crucial due to its progressive nature. However, Alzheimer’s symptoms can resemble those of other non-progressive conditions.
In a recent Cells publication, a team of scientists describe using machine learning models to identify changes in RNA molecules of plasma extracellular vesicles (EVs) that may hold potential for identifying Alzheimer’s disease (AD) at its earliest stages. This is one of the first...
2024-01-3015 min
TGen TalksEpisode 66: The Transformational Power of EducationPaul J. Luna, president and CEO of Helios Education Foundation, sits down with TGen Talks to discuss the transformational power of education, in particular, how internships help prepare students for future success. Helios Education Foundation supports postsecondary attainment for all students, especially low-income and underrepresented communities, in Arizona and Florida.
Earlier this month, Helios committed funding to extend the TGen Bioscience Leadership Academy (TBLA) through 2028 (see related story). TBLA spun out of TGen’s Helios Scholars Program in 2018, with a focus on supporting high-school students interested in careers in biomedical research and medicine.
In addition to the Helios-funded programs at TG...
2023-12-2016 min
TGen TalksEpisode 65 Of TGen TalksMore than three years after the beginning of the pandemic, humans still spread COVID to one another every day, though with less severe symptoms in most cases. Scientists also know that we can spread COVID to our pets as well, because of the close relationships many of us have with our four-legged friends. While dogs CAN get COVID from humans, they don’t seem to get very SICK. So, what’s the big deal if we spread the virus to our pets? Can dogs spread it back to humans or to other animals? TGen scientists are looking to answer these and o...
2023-11-2819 min
TGen TalksEpisode 64: An Insider’s View of TGenToday, the world of biomedical science is changing how we think about disease and, certainly, how we treat it ... but did you ever wonder how discovery happens?
What does a lab look like? What type of equipment do they use? Who exactly is working inside? How many scientists and staff? And on what projects?
On this episode of TGen Talks, Kristen Kaus, Manager of TGen's Education and Outreach programs, talks TGen, specifically, what guests and visitors see and hear when they go on a tour.
While you might not learn everything modern research, you will gain an insider’s knowledge of TGen.
...
2023-09-2715 min
TGen TalksEpisode 63: Unlocking the Secrets of T Cell Therapy ResistanceFor a patient diagnosed with multiple myeloma, a type of blood cancer, there are more treatment options than ever and traditional chemotherapies that cause debilitating side effects have been all but completely replaced by immunotherapies, treatments that help a patient's own immune system better fight the disease. But in many patients, a chosen immunotherapy drug can show great promise in early treatments, yet seemingly stop working altogether as time goes by.
In a paper that was published in Nature Medicine, TGen's Dr. Jonathan Keats explains how upwards of 65% of relapsing multiple myeloma patients could be affected by mutations that impact t...
2023-08-3023 min
TGen TalksEpisode 62: QIIME in if You’ve Heard This One BeforeThe phrase "gut health" has become quite a buzzword in recent years, and researchers like this month's guest will tell you quite candidly that we have a lot to learn about the community of microorganisms that live INSIDE the human body. But one thing seems to be clear. The human being with a "healthy gut" is far better able to fight a cancer diagnosis than the human with poor gut health. Regardless the current standard for a healthy human microbiome, the data being compiled on this relatively new topic is vast. One TGen researcher is uniquely qualified to analyze and...
2023-07-2719 min
TGen TalksEpisode 61: Beyond a Summer of ScienceMost of us had a summer job when we were in high school or college, and if we were lucky, we had one that helped us make meaningful decisions about college or a career.
At TGen, summer interns in the Helios Scholars at TGen program work alongside researchers on projects that are much more than “just” eight weeks of full-time hours inside a lab. Many Scholars choose a field of research they will pursue for an entire career.
On this episode of the TGen Talks, we connect with Heather Mead, Ph.D., a research assistant professor in TGen’s Pathogen and Microbiome Div...
2023-06-2214 min
TGen TalksEpisode 60: Tracking Infection and Immunity Over TimeWhat if you could take a simple test to find out just how susceptible you are to Covid19, the Flu, or any other virus? What if you could test your exposure and immunity to EVERY virus known to mankind using a single drop of blood?
The technology is here, now. And at TGen, researchers are using it to understand the human immune response and predict and track the next global outbreak.
What's more, the human immune system not only protects us from viruses and pathogens, it can help prevent the onset of deadly diseases triggered by those infections. This month's...
2023-05-2516 min
TGen TalksEpisode 59: The Resilience of Maria Fundora and Purple PansiesThis month, our host Karie Dozer sits down for a personal conversation with Maria Fundora, who is neither a scientist nor a clinician. She's a businesswoman from Alpharetta, Georgia, a restauranteur and founder of Purple Pansies, a nonprofit organization dedicated to raising awareness and funds for pancreatic cancer research.
And like most nonprofits that support research, there's a story about how it all began, and most often in whose memory.
Maria's mother passed away from pancreatic cancer in 2007, inspiring Maria to start Purple Pansies. The organization began with $3,500 raised on Mother's Day in 2008. Maria chose the name Purple Pansies because...
2023-04-2817 min
TGen TalksEpisode 57: Yun Rose Li, M.D., Ph.D.When treating cancer patients, physicians are often faced with tough choices. Treatment options like radiation can often come with unpleasant, for some, unbearable side-effects. Doctors walk a fine line between stopping the growth of cancer cells and giving cancer cells the very thing they need to grow and spread.
City of Hope and TGen physician-scientist Yun Rose Li, M.D., Ph.D., has been called trailblazing and innovative by the NIH in her research into oxidative stress and its effects on cancer cells. Dr. Li is using a five year, nearly $2 million grant to study how manipulating oxidative stress can imp...
2023-02-2418 min
TGen TalksEpisode 56: TGen Talks Live, Part IIIn part two of TGen Talks Live, we continue our conversation on precision aging with Drs. Matthew Huentelman and Nicholas Schork.
Aging encompasses a variety aspects—both physical and mental—a fact made evident by the topics covered and the research presented. Where Huentelman’s work covers the brain and the more cognitive aspects of aging, Schork’s work focuses on the physical changes we undergo as we age.
This month, in part two of our live show, our guests talk about how the COVID pandemic affected our bodies and brains, and how we can best separate fact from fiction when it...
2023-01-2517 min
TGen TalksTGen Talks Live (part 1)TGen offers listeners a deeper dive into a particular biomedical-related topic or program through its monthly podcast TGen Talks. Each free-flowing episode allows a TGen scientist to connect with a broader audience by explaining the finer details involved in their research at a listener-friendly level.
December’s episode escapes the sound booth for a live event in front of a studio audience. The inaugural TGen Talks Live features Drs. Matthew Huentelman and Nicholas Schork who join our host Karie Dozer for an in-depth conversation on precision aging.
A continuation of TGen’s 20th Anniversary celebrations, the event, hosted by the TGen...
2022-12-2019 min
TGen TalksEpisode 54: Precision AgingHumans have been searching for the fountain of youth (a mythical endless supply of waters that purport to keep us young forever) for thousands of years—but there’s no such thing in the world of science.
At TGen, scientists are working toward a virtual fountain of youth, and they call it precision aging.
On this month’s TGen Talks, Matthew Huentelman, Ph.D., helps us understand precision aging a bit more clearly, as he explains the concepts behind the process, and discusses just a few of the benefits it may hold for our future. This month’s podcast also tees up...
2022-11-2216 min
TGen TalksEpisode 53: Vidium: A Dog’s Best FriendCancer is the number one worry of pet parents, and it's no wonder. More than half of all dogs older than 10 will be diagnosed with cancer. Cancer is hard to treat in many dogs, and is often diagnosed when it's too late to treat. Americans spent more than $120 billion on their pets just last year. One TGen subsidiary is putting its science to work for pet parents, so that cancer in dogs is diagnosed before it's too late. Vidium Animal Health is a wholly owned subsidiary of TGen and it works to diagnose and treat canine cancers.
2022-10-2515 min
TGen TalksEpisode 52: Number One WorldwideWith COVID infections and deaths on the decline worldwide, many researchers are turning their attention back to a familiar foe. Tuberculosis (TB) was the number one infectious disease killer before the emergence of COVID-19, and it is number one again today.
Although most Americans are not at risk of contracting TB, it continues to be a danger worldwide. TGen researchers are trying to find better diagnostics for this very stubborn bacterial infection, and combat antibiotic resistance so that doctors everywhere can better treat this ancient illness.
TGen North research scientist Megan Folkerts joins TGen Talks to discuss TB’s history, Egyp...
2022-09-2914 min
TGen TalksEpisode 51: In Search of OutbreaksFor Crystal Hepp, PhD, the newest member of the TGen North team, understanding how different pathogens move over time and space and through different populations is all in a day’s work. Recently, that work has centered heavily on RNA viruses, and given that the translational aspects of her work aligned seamlessly with the TGen North team and its mission, the decision to join the team came fairly easy.
Spread through the bite of the common house mosquito, West Nile virus is the leading cause of mosquito-borne disease in the United States. Hepp discusses her work with county vector control ag...
2022-08-2415 min
TGen TalksEpisode 50: The World of PathogensThis episode of TGen Talks takes the listener along I-17 from Phoenix to Flagstaff, where our host, Karie Dozer, sits down with David Engelthaler, Ph.D., professor and director of TGen’s Pathogen and Microbiome Division, more commonly known as TGen North.
Whereas TGen uses genomics to solve complex problems such as cancer and Alzheimer's disease, the scientists at TGen North use these same tools and technology to focus on infectious disease … the microbes, the bacteria, the viruses, the fungi that cause some of the greatest problems around the world.
Engelthaler provides the listener an inside look at the research underway ac...
2022-07-1917 min
TGen TalksEpisode 49: Nonalcoholic Liver DiseaseDr. Johanna DiStefano joins TGen Talks to discuss nonalcoholic fatty liver disease, or NAFLD, a condition that causes excess amount of fat in one’s liver cells. As evidenced by its name (which could use an update, according to our guest) NAFLD covers a wide-range of liver conditions with the “alcohol” portion somewhat misleading, as it’s not always that cut and dry.
Different factors, such as genetics, lifestyle, and diet could also play a role in NAFLD. It could also be one’s gender or one’s stage in life. For example, the risk increases for women following menopause.
Dr. DiStefano...
2022-06-2114 min
TGen TalksEpisode 48: Celebrating 20 Years of Precision MedicineThis year marks the 20th anniversary of TGen's founding on what at the time was a relatively unknown idea outside the circles of academia and scientific research, precision medicine. The concept of using a person's own genome to diagnose and treat disease at an individual level, to move beyond the one-size-fits-all treatment plans that had dominated the medical landscape for decades, where drugs and therapies considered large groups of people with the same disease, and what worked for the majority.
A true public-private partnership, TGen came to fruition through the work of tribal leaders, CEOs, philanthropic trusts, foundations, individuals and...
2022-05-2418 min
TGen TalksEpisode 47: Math Meets CancerApplied mathematics dramatically advanced the field of finance in the 1970’s, where its application allowed for the modeling of financial markets by mathematicians highly skilled in quantitative analytics. Today, these highly sought-after mathematicians are making a name for themselves in the field of applied science as their skills are increasingly providing solutions in many areas of biomedical research.
The genomic sequencing routinely employed by TGen in precision medicine platforms generates data on a massive scale. Applying mathematical modeling, statistical methods, and machine learning, to these complex datasets has the potential to transform longitudinal (i.e., the same patient sampled over time...
2022-03-3017 min
TGen TalksEpisode 36: New Tech STARTS HereTGen’s Scientific Technology Assessment Research Team (START) supports the research faculty by bringing new technology into the labs to help answer today’s most pressing research questions.
When the current tools for measuring DNA or proteins or cellular structure aren't sufficient, START scouts the technology landscape for companies that are developing new methods that can, often by partnering to beta test the technology. And that means TGen gains early access … but only after the START lab vets the technology through rigorous testing at a biological level.
Stephanie Pond, Ph.D., Vice President of Emerging Technologies and head of TGen's START pro...
2022-02-2314 min
2022-01-2617 min
TGen TalksEpisode 44: Are We There Yet? COVID, Omicron and the Year AheadFor our final episode of TGen Talks in 2021, our host, Karie Dozer, sat down with TGen North Director, Dr. David Engelthaler, who has led TGen’s research into COVID since day one.
Dr. Engelthaler shares his thoughts on Omicron … what we know, what’s left to learn, and why it’s spreading so fast.
While it may be a bit early to predict how Omicron will play out in the U.S., it appears to follow trends seen with other variants and is on pace to replace Delta as the most dominant variant, which may not be all bad news, particularly i...
2021-12-1518 min
TGen TalksEpisode 43: The Genomics of Brain TumorsGenomic analysis of a cancer tumor is fairly common these days. Researchers sequence and compare a patient’s non-cancerous DNA with their tumor DNA to identify changes that may allow a patient to receive medicine that specifically targets those changes. But what happens when the tumor comes back? Has the tumor changed? And if so, how?
These were questions that intrigued TGen Assistant Professor Floris Barthel, M.D. In particular, his latest research focuses on the effects of radiotherapy on the cancer tumor. What is different in the DNA of the first tumor compared to the normal DNA, and what is...
2021-11-2317 min
TGen TalksEpisode 42: An Inside Look at the World of Rare Disease ResearchAt the Center for Rare Childhood Disorders, it's all about the kids. Center staff dedicate themselves to finding a diagnosis and possible treatments for disorders so rare that many may not even have a name.
In episode 42 of TGen Talks, we go inside the Center with Clinical Director Keri Ramsey, who talks about the parents and kids who come to the Center for answers, and how TGen scientists are solving as many of these medical mysteries as possible ... some years after the search began through a special program that brings cold cases to the forefront and offers renewed hope to families...
2021-10-2717 min
TGen TalksEpisode 41: Takin' it to the Streets- Reimagining ResearchFor TGen’s Dr. Matt Huentelman, leveraging today’s technology to rewrite the playbook on research recruiting and reimagine the scientific landscape involves attracting people to genomic studies in a whole new way. Leaning on a riff from the Doobie Brothers, Huentelman wants to take it to the streets.
The Internet — in one form or another — has been around since the late 1960s, yet it’s only been within the last decade or so that scientists have taken advantage of online platforms to recruit for and drive large-scale research studies. For Huentelman, his MindCrowd study was among the early adopters and today...
2021-09-2918 min
TGen TalksEpisode 40: Helios Scholars at TGenThe range of emotions a Helios Scholar at TGen experiences — from application through the program’s end — shifts dramatically as the summer unfolds. The end result, however, is one of accomplishment.
2021 marked the 15th year of TGen’s flagship internship program that has seen nearly 600 alumni gain often career-defining exposure to biomedical research and medicine by working alongside TGen faculty and staff.
In episode 40, TGen Talks host Karie Dozer sits down with three Helios Scholars from the class of 2021 who share their summer of science as they discuss what they've learned and how they'll put that training to use as they mov...
2021-08-2617 minTGen TalksEpisode 40, Helios Scholars at TGenThe range of emotions a Helios Scholar at TGen experiences — from application through the program’s end — shifts dramatically as the summer unfolds. The end result, however, is one of accomplishment.
2021 marked the 15th year of TGen’s flagship internship program that has seen nearly 600 alumni gain often career-defining exposure to biomedical research and medicine by working alongside TGen faculty and staff.
In episode 40, TGen Talks host Karie Dozer sits down with three Helios Scholars from the class of 2021 who share their summer of science as they discuss what they've learned and how they'll put that training to use as they mov...
2021-08-2617 min
TGen TalksEpisode 38: COVID-19: Mother Nature’s Work or Something Else?With the Delta variant of COVID-19 garnering worldwide attention, it begs the question: When will the pandemic end? This month, on Episode 38, we circle back with David Englethaler, Ph.D., Director of TGen's Pathogen and Microbiome Division, more commonly known as TGen North, for an update on all things COVID-19 related. How much longer will we be dealing with COVID-19? Do we really know where COVID came from? Will we need vaccinations against COVID for years to come? Dr. Engelthaler answers these questions, and also explains how TGen is working with local and state health officials to track variants of...
2021-06-2916 min
TGen TalksEpisode 37: TGen Advances in DIPG Research and the Story of Most Best DaysHearing the words you have cancer comes as a shock. Hearing that your child has cancer is almost unimaginable. And when you learn that it is a rare form of brainstem cancer known as diffuse intrinsic pontine glioma or DIPG — a central nervous system cancer that forms from glial cells, the supportive tissue of the brain and spinal cord that affects less than 300 children per year — the questions become endless.
Joining TGen Talks is Dr. Michael Berens, professor and director of TGen’s Cancer and Cell Biology Division and head of the Glioma Research Laboratory, whose research efforts focus on conducti...
2021-04-2721 min
TGen TalksEpisode 36: Precision Medicine for PetsAt TGen, scientists have studied naturally occurring cancer in canines for over a decade. This expertise led to the formation of a company aimed specifically at partnering with veterinarians to identify treatment options for our four-legged friends and bring greater peace of mind to pet parents.
Vidium Animal Health was launched in September of 2020, to provide genomic based precision medicine to veterinary oncologist through its flagship test Searchlight DNA.
Searchlight DNA was designed to specifically identify any of the nearly 120 known cancer associated genetic mutations in dogs and to use the molecular profile of misbehaving genes to help guide diagnosis and...
2021-03-3014 min
TGen TalksEpisode 35: Diagnosing Rare DisordersAt TGen's Center for Rare Childhood Disorders, we are committed to developing, refining, and applying the latest tools of genomic medicine to help diagnose and direct treatment for children with rare diseases and disorders.
Did you know that there are over 7,000 rare diseases that affect over 25 million Americans? Many of these patients endure a diagnostic odyssey that involves multiple tests and doctor visits that all too often are expensive and painful, yet offer no additional clues.
To address this challenge, TGen established the Center for Rare Childhood Disorders in 2012 with the goal of using advanced genomic testing to identify the...
2021-02-2322 min
TGen TalksEpisode 34: The Vaccine EditionIt took under a year to develop, test and begin to deploy vaccines against COVID-19. And despite a few hiccups upon arrival, the rollout is underway... and that's great news for a world that's nearing 100 million cases and over 2 million deaths.
Joining TGen Talks to discuss his take on COVID-19 vaccines is Dr. David Engelthaler, Director of TGen North, the Pathogen and Microbiome Division of TGen located in Flagstaff, Arizona.
Dr. Engelthaler discusses the vaccine's available today, those that are currently in the development pipeline and why getting vaccinated is important. He also tackles the known side-effects, the speed at wh...
2021-01-2615 min
TGen TalksEpisode 33: Helios Scholar Shares AllInternships provide students an opportunity to learn more about potential career choices and equally important, following the experience, gauge whether that career is right for them. Joining TGen Talks is Josh Niska, MD — a 2007 Helios Scholar at TGen — who explains the value of his Helios internship experience, how it helped shape his career, and how the lessons learned at the bench continue to inform his work as a radiation oncologist.
He explains how the technologies and techniques and concepts he learned at TGen helped with his undergraduate education, medical school, residency and his work today. He also discusses the importance of mento...
2020-12-1617 min
TGen TalksEpisode 32: Side-By-Side With ExpertsFor 45 students, Summer 2021 could be life-changing … an opportunity to look into the future of biomedical science and see where their own careers could lead them. It’s possible thanks to The Helios Education Foundation and TGen.
For 14 years, these forward-thinking organizations have offered gifted students the opportunity to work on real-life projects as paid interns, side-by-side with skilled TGen mentors.
In this podcast, learn how this program has been a springboard to inspiring careers and find out how the next generation of students can apply to change their lives.
2020-11-1914 min
TGen TalksEpisode 31: Make It PersonalRecent events and social protests have prompted increased dialog, and rightly so, on the topic of diversity, equity, and inclusion in America. It's a big topic that covers multiple segments of society. But this edition of TGen Talks will focus on how diversity relates to the fields of science and medicine.
Our guest this month on TGen Talks is Dr. Joseph Mikhael, professor of Applied Cancer Research and drug discovery at TGen and Chief Medical Officer of the International Myeloma Foundation, or IMF, and a counselor on the Executive Committee of the American Society of Hematology, who shares his insights on...
2020-10-2026 min
TGen TalksEpisode 30: Are We There Yet?275 days ago, the Wuhan Municipal Health Commission in China reported a cluster of cases of pneumonia … a novel coronavirus was eventually identified and labeled COVID-19.
Since that time, over 200,000 Americans have died and over 7.1 million have tested positive for the disease. Globally, the number of deaths has reached 1 million with more than 33 million citizens testing positive.
Our guest this month on TGen Talks is Dr. David Engelthaler, co-director of TGen North, the Pathogen and Microbiome Division of TGen located in Flagstaff, Arizona, who shares his insights on the latest information and developments surrounding COVID-19 — locally and globally — from testing to the valu...
2020-09-2315 min
TGen TalksEpisode 29: Expressions of InterestImmune cells, also known as white blood cells, help the body fight infection and disease. Now, scientists and clinicians at TGen and City of Hope are using immune cells in combination with chemotherapy drugs to tailor personalized treatments for cancer patients. Specifically, they're using a mathematical formula to predict who might respond best to this type of therapy.
This month on TGen Talks, Sunil Sharma, M.D, TGen Deputy Director of Clinical Sciences and Director of the Applied Cancer Research and Drug Discovery Division discusses immunotherapy, this latest advance, and how it could lead to the development of innovative clinical tr...
2020-07-2829 min
TGen TalksEpisode 28: A Fresh look at COVID-19Following the lifting of social restrictions and individuals returning to work, the medical profession has seen a recent spike in COVID-19 cases. This month on TGen Talks, Tyler Delaughder, D.O., a TGen clinical research coordinator and recent graduate of Midwestern University, shares his interpretations of the medical issues surrounding COVID-19.
Dr. Delaughder provides insight on the progress of testing and what we might expect next by looking into the past, identifying human error, understanding the power of Mother Nature, and the body’s own genomic complexities. Is there a way of stopping future viruses from developing or are they inevita...
2020-06-2515 min
TGen TalksEpisode 27: Lessons Learned, COVID-19For nearly 6 months, COVID-19 has raised numerous questions and concerns, as well as having led to global disruption. In addition to testing, TGen was an early adopter in tracking the virus to learn how it mutates and spreads. Joining TGen Talks to discuss what we've learned is Dr. David Engelthaler, co-director of TGen North, the Pathogen and Microbiome Division of TGen located in Flagstaff, Arizona.
Dr. Engelthaler discusses what the epidemiology is telling us about COVID-19, and how that plays into decisions states are making on whether to open, and if so, how broadly? He also discusses the global effort to...
2020-05-2716 min
TGen TalksEpisode 26: COVID-19 ImmunityWhat can a few drops of blood tell scientists about how one’s immune system reacted to COVID-19? If you’re TGen North’s Dr. John Altin, you hope a lot.
In this episode of TGen Talks, Dr. Altin discusses a new study entitled the COVID Immunity Study whereby citizen-scientists diagnosed with, and subsequently recovered from, COVID-19 can contribute a few blood spots that will enable Dr. Altin to investigate the antibody response against the SARS-CoV-2 virus, which causes the COVID 19 disease. Through his study Dr. Altin, an Assistant Professor in TGen’s Pathogen and Microbiome Division, hopes to find antibody s...
2020-04-2411 min
TGen TalksEpisode 25: Investigating COVID-19The COVID-19 coronavirus continues to affect lives on a daily basis. Businesses, churches, schools, and other public facilities are closing. Sporting events and meetings are canceled daily. News reports tell us how hospitals are grappling with limited testing capabilities. There seem to be more questions than answers, and if ever there was a time for answers, it is now. Joining TGen Talks to discuss COVID-19, is Dr. David Engelthaler, co-director of TGen North, the Pathogen and Microbiome Division of TGen located in Flagstaff, Arizona, who discusses the launch of a genomic-based test for COVID-19, and TGen’s collaborative work with th...
2020-03-1714 min
TGen TalksEpisode 24: Reading the Story of TumorsOur DNA tells the story of who we are genetically. But when we develop cancer, our tumor DNA tells a different version of that story.
At Ashion Analytics, a subsidiary of TGen, a patient's tumor sample undergoes testing in a CLIA-certified laboratory —through its flagship test, GEM ExTra— to understand how the story changed and how Ashion can help treating physicians identify actionable steps to help their patients.
In episode 24 of TGen Talks, Dr. Janine LoBello, Medical Director and Pathologist of Ashion Analytics, discusses Ashion's beginnings, how their services benefit medical professionals, and a few interesting facts you may not know...
2020-02-1814 min
TGen TalksEpisode 23: Tracking Glioblastoma Cell by CellThe human body contains trillions of individual cells, and inside each resides a unique genetic code. Single-cell RNA sequencing enables researchers to study the mechanics of individual cells and identify the processes underlying disease states — valuable information that helps predict disease susceptibility, or resistance, to drug therapies.
This is particularly important in the study of cancer, as cells are constantly mutating. Single-cell sequencing allows investigators to observe these patterns of mutations at a micro-level. In episode 23 of TGen Talks, Dr. Sen Peng, a computational scientist with TGen’s Brain Tumor Unit, discusses how data from single-cell sequencing allows Dr. Peng and his...
2020-01-2807 min
TGen TalksEpisode 22: Clinical Trials, Drug Development & The Future of Precision MedicineOver the past decade, cancer treatment has gone from a one-size-fits-all approach to a targeted and personal approach known widely as Precision Medicine.
Among the leaders at TGen pushing the boundaries of this new frontier is Dr. Sunil Sharma, Deputy Director of TGen Clinical Sciences, Professor, and Division Director in the Applied Cancer Research and Drug Discovery division.
Dr. Sharma is a well-known cancer investigator, responsible for helping develop some of the world’s most advanced anti-cancer agents.
In episode 22 of TGen Talks, Dr. Sharma discusses his work in drug development and patient clinical trials in concert with City of Hope in...
2019-12-1917 min
TGen TalksEpisode 21: Why We Care About Fatty LiverExperts aren’t sure why some people accumulate fat in the liver while others do not, but they all agree it’s a serious health issue.
One type, known as nonalcoholic fatty liver disease — or NAFLD — is a collection of liver conditions affecting people who drink little to no alcohol. It’s also the most common form of chronic liver disease and is tied closely to diabetes.
In episode 21 of TGen Talks, Johanna DiStefano, Ph.D., a Professor in TGen’s Quantitative Medicine and Systems Biology Division and Head of its Diabetes and Fibrotic Disease Unit discusses the connections between NAFLD and di...
2019-11-2008 min
TGen TalksEpisode 20: Turns Out, Rare Isn't So RareDon't let the word rare fool you. Roughly 1-in-10 individuals in the world are affected by a rare disease, and our Center for Rare Childhood Disorders is on a mission to find diagnoses and treatments for these individuals and families.
In episode 20 of TGen Talks, Center co-director, Keri Ramsey, explains the advances science has made in genetic sequencing and how we've applied it to help our patients through treatments, gene therapy, and FDA drug testing. Listen to learn more about how our Center and its donors are impacting the lives of our community.
2019-10-2409 min
TGen TalksEpisode 19: Breathing Life Into ResearchThe offer of help to a family friend created a serendipitous chain of events that led Dr. Nick Banovich to study Idiopathic Pulmonary Fibrosis (IPF).
IPF is a type of lung disease that scars the lungs and as it worsens makes it for the lungs to take in enough oxygen.
In episode 19 of TGen Talks, Dr. Banovich explains how the right collaboration and today's technology make it possible to examine individual cells, rather than a mash-up of many cells from a tissue sample, to identify gene expression changes associated with IPF, work that is breathing new life into research surrounding I...
2019-09-1911 min
TGen TalksEpisode 18: Stirring Up A Whole Lot of Science Around Valley FeverTGen North's Dr. David Engelthaler discusses Valley Fever. We learn why Arizona - with nearly 65% of all Valley Fever cases in the U.S.- is the perfect hotbed for research into this debilitating and potentially lethal disease, and how TGen North is tracking this warm-climate invader and adapting today's technology to provide much needed answers to this age-old problem.
2019-08-2010 min
TGen TalksEpisode 17: A Deeper Look at ProteomicsPatrick Pirrotte, Ph.D., Assistant Professor of the Cancer and Cell Biology Division and the Director of TGen's Collaborative Center for Translational Mass Spectrometry discusses the role of proteomics in cancer research, and finding new targets for cancer treatment.
2019-07-1904 min
TGen TalksEpisode 16: Comparative Oncology Provides Deeper Insight into CancerTGen Assistant Professor, Dr. Will Hendricks, discusses comparative oncology, a field of study that in recent years has gained in popularity, as it seeks to integrate information from naturally occurring cancers in pets into what we know about the biology of cancer in humans.
2019-06-2009 min
TGen TalksEpisode 15: MindCrowd—A Study on how the Healthy Brain WorksMindCrowd, launched seven years ago by Dr. Matthew Huentelman, studies the healthy brain. At its core, MindCrowd offers a new way approach scientific research to learn how the brain functions and how genetics influences memory.
2019-05-2911 min
Graduating in Science... Now What?Episode 4 - TGenSo many science students at ASU are interested in pursuing a career in genetics or biotechnology. This is why Dr. Austin decided to speak with our guest speakers at the Translational Genomics Research Institute (TGen)!
TGen is a prominent genomics research institute in Arizona and the home of the Helios Scholars Program, which has provided countless undergraduate research opportunities to our ASU students. In this podcast, Dr. Austin speaks with TGen's Manger of Education and Outreach, Ms. Julie Euber, and Research Scientist, Ms. Amanda Courtright-Lim, as they give advice on how to apply to research positions as an undergraduate student.
...
2019-05-2400 min
TGen TalksTiny Microbes A Big Deal for Dr. Sarah HighlanderMicrobes out-number the genes in your DNA by more than 1,000 to 1 and together they make up what is known as your microbiome. TGen’s Dr. Sarah K. Highlander, a research professor in the Pathogen and Microbiome Division at TGen North and director of the Clinical Microbiome Service Center, works to understand the microbiome and how it is helping scientists better understand cancer, diabetes and a host of other conditions, including traveler’s diarrhea.
2019-04-1709 min
TGen TalksEpisode 13: AI and Big Data with Dr. Glen OteroDr. Glen Otero, a 20 year veteran of life science industry and an expert in high-performance computing, discusses artificial intelligence, or A.I., and how it addresses the computational needs of the biomedical research community by executing tasks more rapidly and without human error in a fraction of the time. Today, A.I. is used to process complex genomic data sets to accelerate delivery of personalized treatments for cancer and other diseases by turning raw genomic data —such as a human genome sequence— into usable information to predict disease patterns and treatment outcomes.
2019-03-2008 min
TGen TalksEpisode 12: TGen Talks — Tracking Neurodegenerative Disorders With BiomarkersIn medicine, a biomarker is anything used to determine the presence or development of a particular disease or biological state. They can be used to determine if an injury or disease has occurred, or even if a therapy is working. In this episode, Dr. Kendall Van Keuren-Jensen, a Professor in TGen Neurogenomics Division and Co-Director of TGen’s Center for Noninvasive Diagnostics, discusses how her team is working on ways to use biomarkers — in this case the molecular readout of RNA — as a non-invasive method for studying and treating complex diseases, such as those that affect the nervous system.
2019-01-2909 min
TGen TalksEpisode 11: Outside Influence: Stimuli, Epigenomics, and Changing Cell BehaviorNature vs. nurture? How about nature and nature? Dr. Candace Lewis, a postdoctoral fellow in the Huentelman lab at TGen, walks us through a biological regulatory framework known as epigenomics that changes the behavior of our cells due to our life experiences. Dr. Lewis also discusses the resurgence in psychedelic assisted therapy to treat depression and trauma, and her work in Autism.
2018-12-1308 min
TGen TalksEpisode 10: TGen Talks Takeover - Your Best AdviceHelios Scholar Mario Mosqueda asked 10 TGen scientists for their best career advice in an insightful discussion on charting a path in science.
2018-10-2519 min
TGen TalksDid You Know? Postdocs Are People TooDid You Know? There are fellows - and ladies - that work in the lab to learn how to lead a lab. They're called 'postdocs.'
2018-09-1803 min
TGen TalksEpisode 9: Meet Steve, Pancreatic Cancer SurvivorSteve, a four-year pancreatic cancer, survivor shares his story of hope.
2018-08-1112 min
TGen TalksEpisode 8: Students Takeover TGen Talks - Discovery Ensues!Students from the inaugural TGen Bioscience Leadership Academy took over the TGen Talks podcast to discuss what they learned during their two-week, immersive summer experience at TGen.
2018-07-2611 min
TGen TalksDid You Know? Single-Cell SequencingSingle-Cell Sequencing promises to bring more precision to 'precision medicine.' Learn how this new technique could revolutionize diagnosis and treatment from Dr. Jonathan Keats.
2018-06-1404 min
TGen TalksEpisode 7: Computing Horsepower with James LoweyJames Lowey, TGen's Chief Information Officer, discusses how high-performance computing has revolutionized genomics and how our partnership with Dell has created a powerful platform to transform health.
2018-05-0110 min
TGen TalksEpisode 6: Mom-To-Be Makes Ovarian Cancer DiscoveryDr. Jessica Lang, a mother-to-be, discusses a new treatment discovery for ovarian cancer, the deadliest reproductive cancer.
2018-04-1709 min
TGen TalksEpisode 5: Understanding Multiple MyelomaDr. Jonathan Keats discusses how multiple myeloma can be multiple cancers from a genetic standpoint. Through his work with the Multiple Myeloma Research Foundation's CoMMpass Study, Dr. Keats' team has sequenced 1,150 patients from 90 sites worldwide. What does this mean for patients?
2018-03-2209 min
TGen TalksDid You Know? Computer Science vs Lab ScienceDid You Know? Bioscience is as much about computer science as it is about laboratory science! Make yourself smarter in 2 minutes with our latest TGen Talks podcast!
2018-03-2002 min
TGen TalksEpisode 4: What Is CAR T Therapy?Dr. John Altin explains how a patient's own immune cells can be transformed into cancer-killers through CAR T therapy — and what this means for the future of cancer treatment.
2018-02-2212 min
TGen TalksEpisode 3: The Diagnostic OdysseyTGen's Center for Rare Childhood Disorders provides genetic testing to give hope and answers to rare disease patients. As part of their summer project, our Helios Scholars at TGen interns, Hannah and Morgan, interviewed one of our families about their years-long journey to a diagnosis.
2018-01-2215 min
TGen TalksDid You Know? Arsenic vs GlioblastomaArsenic is a poison, commonly associated with murder mysteries, but did you know that it can be an effective cancer-killer? Learn more from disease detective Dr. Harshil Dhruv at TGen.
2018-01-0903 min
TGen TalksEpisode 2: Dr. Michael Berens Talks GlioblastomaGlioblastoma is the deadliest cancer. It has been in the news lately because of the recent diagnosis of Senator John McCain and former Vice President Joe Biden's Moonshot Initiative. What is glioblastoma and why is it so hard to treat?
2017-12-1813 min
TGen TalksEpisode 1: What is TGen? Interview with Dr. Jeffrey TrentWelcome to TGen Talks! Dr. Jeffrey Trent, former Research Director for the Human Genome Project, and current President of the Translational Genomics Research Institute, talks about how we use genes to discover the causes of serious diseases and develop smarter treatments for them. Everything from Alzheimer's to Zika virus.
2017-12-0512 min
Arizona OriginalsDr. Michael Berens - TGenDr. Michael Berens from TGen shares his story and provides insight into leading a world-class genetics research team. He speaks of the importance of mentoring, the value of family, the latest cutting edge genetics research going on at TGen, and much more.
2016-09-1933 min
Battle BardsBattle Bards News and TGEN Tribunal Episode 4: Virtual Reality, E-Begging and Non-Combat GamesToday, the Battle Bards are back for a special update and podcast episode!
First things first, for all those of you who frequent twitter and would like to receive regular updates on our shows as well as MMO music in general, you can now follow us via our official twitter feed @battlebardscast. Don't hesitate to contact us there or leave feedback or suggestions on twitter in the future - we love to hear from you!
As some of you know, Battle Bards is part of The Gaming and Entertainment Network, a free collaboration of independent...
2016-02-291h 00Battle BardsBattle Bards News and TGEN Tribunal Episode 4: Virtual Reality, E-Begging and Non-Combat GamesToday, the Battle Bards are back for a special update and podcast episode!
First things first, for all those of you who frequent twitter and would like to receive regular updates on our shows as well as MMO music in general, you can now follow us via our official twitter feed @battlebardscast. Don't hesitate to contact us there or leave feedback or suggestions on twitter in the future - we love to hear from you!
As some of you know, Battle Bards is part of The Gaming and Entertainment Network, a free collaboration of independent...
2016-02-291h 00
Can You Dig It? PodcastCYDI 20 - Portability and ControversyWelcome to the Can You Dig It? Podcast! In this episode, Scott and Walshy discuss Minecraft Pocket Edition on iOS, MineCon and some dramas it brought with it. Congratulations to Mojang and the Minecraft community for getting this far and for just being an amazing group of people! Enjoy! Visit http://canyoudigitpodcast.com for more information.
2014-12-1410 minCan You Dig It? PodcastCYDI 19 - Minecraft 1.0!Welcome to the Can You Dig It? Podcast! MINECRAFT 1.0!! What has changed? Not a lot :) But in this information packed episode Scott brings us news and information from Minecraft's Official Release at MineCon! This is also our first LIVE podcast so we apologise for any audio quality issues. Enjoy! Visit http://canyoudigitpodcast.com for more information.
2011-11-1910 minCan You Dig It? PodcastCYDI 18 - CYDI Live!Welcome to the Can You Dig It? Podcast! In this episode, Scott updates us on the progression of the Minecraft 1.9 Beta's, with Pre-release 6 which includes 'The End', as well as the Minecraft Release Candidate 2. Also Crafted, a 2D Minecraft iOS Clone has been pulled, Minecraft on iOS?As well as our first LIVE Podcast! It coincides with the Keynote Address at MineCon! The Stream will run from around 1pm to 3pm on Friday the 18th of November in Las Vegas (PST), or 8am to 10am on Saturday the 19th in Australia (AEDT). Don't forget...
2011-11-1510 minCan You Dig It? PodcastCYDI 16 - Pre-release Mania!Welcome to the Can You Dig It? Podcast! In this episode, Scott and Walshy discuss Minecraft Beta 1.9 Pre release 5 and give us all an update on TGEN. Enjoy! Visit http://canyoudigitpodcast.com for more information.
2011-11-0110 min